75 related articles for article (PubMed ID: 17928924)
41. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens.
Young KG; Haq K; MacLean S; Dudani R; Elahi SM; Gilbert R; Weeratna RD; Krishnan L
J Viral Hepat; 2018 Jun; 25(6):649-660. PubMed ID: 29316037
[TBL] [Abstract][Full Text] [Related]
42. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
Wang LH; Huang W; Lai MD; Su IJ
Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
44. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
[TBL] [Abstract][Full Text] [Related]
45. Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.
Rahbin N; Frelin L; Aleman S; Hultcrantz R; Sällberg M; Brenndörfer ED
Biochem Biophys Res Commun; 2013 Mar; 433(1):31-5. PubMed ID: 23454379
[TBL] [Abstract][Full Text] [Related]
46. [Human normal biliary epithelial cells transformation and tumor development induced by hepatitis C virus core protein].
Chen RF; Li ZH; Chen JS; Kong XH; Zou SQ
Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):153-6. PubMed ID: 15842891
[TBL] [Abstract][Full Text] [Related]
47. [Study on tumor formation of hepatocyte transformed by hepatitis B virus X gene in nude mice.].
Zheng F; Liu GZ; Li T; Tan DM
Zhonghua Gan Zang Bing Za Zhi; 2009 Feb; 17(2):117-9. PubMed ID: 19254459
[TBL] [Abstract][Full Text] [Related]
48. HCV non-structural NS4A protein of genotype 3a induces mitochondria mediated death by activating Bax and the caspase cascade.
Javed F; Manzoor S
Microb Pathog; 2018 Nov; 124():346-355. PubMed ID: 30179714
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
Tiwari I; Yoon MH; Park BJ; Jang KL
Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
51. Activation of c-Yes in hepatocellular carcinoma: a preliminary study.
Feng H; Masaki T; Nonomura T; Morishita A; Jian G; Nakai S; Deguchi A; Uchida N; Himoto T; Iwama H; Usuki H; Wakabayashi H; Izuishi K; Yoshiji H; Kurokohchi K; Kuriyama S
World J Gastroenterol; 2006 Sep; 12(35):5743-5. PubMed ID: 17007035
[No Abstract] [Full Text] [Related]
52. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors.
Akkari L; Grégoire D; Floc'h N; Moreau M; Hernandez C; Simonin Y; Rosenberg AR; Lassus P; Hibner U
J Hepatol; 2012 Nov; 57(5):1021-8. PubMed ID: 22750466
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells.
Sakamuro D; Furukawa T; Takegami T
J Virol; 1995 Jun; 69(6):3893-6. PubMed ID: 7745741
[TBL] [Abstract][Full Text] [Related]
55. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus.
Yokoyama Y; Kuramitsu Y; Takashima M; Iizuka N; Toda T; Terai S; Sakaida I; Oka M; Nakamura K; Okita K
Proteomics; 2004 Jul; 4(7):2111-6. PubMed ID: 15221772
[TBL] [Abstract][Full Text] [Related]
56. Genetic background of hepatocyte cell lines: are in vitro hepatitis C virus research data reliable?
Bensadoun P; Rodriguez C; Soulier A; Higgs M; Chevaliez S; Pawlotsky JM
Hepatology; 2011 Aug; 54(2):748. PubMed ID: 21384407
[No Abstract] [Full Text] [Related]
57. In vitro expression of hepatitis C virus non-structure 5 antigen in the HepG2 cell line.
Ye J; Zeng L; Yang M; Luo D; Guo J
J Tongji Med Univ; 2000; 20(4):277-9. PubMed ID: 12840910
[TBL] [Abstract][Full Text] [Related]
58. HCV core protein represses the apoptosis and improves the autophagy of human hepatocytes.
Liu C; Qu A; Han X; Wang Y
Int J Clin Exp Med; 2015; 8(9):15787-93. PubMed ID: 26629077
[TBL] [Abstract][Full Text] [Related]
59. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.
Shirvani-Dastgerdi E; Schwartz RE; Ploss A
Curr Opin Virol; 2016 Oct; 20():1-10. PubMed ID: 27504999
[TBL] [Abstract][Full Text] [Related]
60. Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy.
Xiao X; He Q; Huang K
Med Oncol; 2010 Dec; 27(4):1200-7. PubMed ID: 19949900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
